US Patent Issued to Novartis on Sept. 2 for "Compounds and compositions for treating conditions associated with cGAS" (Swiss, French, German Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,261, issued on Sept. 2, was assigned to Novartis AG (Basel, Switzerland).

"Compounds and compositions for treating conditions associated with cGAS" was invented by David Carcache (Binningen, Switzerland), Florian Gruber (Sissach, Switzerland), Danilo Guerini (Reinach, Switzerland), Martin Gunzenhauser (Gelterkinden, Switzerland), Richard Heng (Hegenheim, France), Francesca Perruccio (Basel, Switzerland), Oliver Simic (Basel, Switzerland) and Carsten Spanka (Lorrach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a compound of Formula (I):or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, ...